Skip to main content

Table 1 Discrepancies between reported and documented medications prescribed for the management of liver-related complications

From: Prevalence of medication discrepancies in patients with cirrhosis: a pilot study

Number of liver medicationsa

Patient reported but not documented in medical record

Documented in medical record but not reported by patient

Concordant medications

Proportion (%) discordant records within drug-disease category

Diuretics n = 16

1

2

13

18.8 %

Propranolol n = 9

0

0

9

0.0 %

Cholecalciferol n = 8

4

0

4

50.0 %

PPIs n = 7

2

1

4

42.9 %

Thiamine n = 6

1

0

5

16.7 %

Lactulose n = 5

0

3

2

60.0 %

Antivirals n = 4

0

0

4

0.0 %

Other n = 9b

3

1

5

44.4 %

  1. aExcluding 6 liver medications which were only documented in ELMs (n = 1 for thiamine, rifaximin, PPI, lactulose, cholecalciferol, spironolactone)
  2. bRifaximin, spontaneous bacterial peritonitis prophylaxis, ursodeoxecholic acid, other vitamins and protein supplements prescribed for complications of cirrhosis